Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher R Williams

Showing results (41-50 of 54) with videos related to

Pageof 6
Sort By:
Psycho-Oncology|September 30, 2010
A pilot investigation of a multidisciplinary quality of life intervention for men with biochemical recurrence of prostate cancerSteven C Ames, Winston W Tan, Gretchen E Ames, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trialsRandal H Henderson, Bradford S Hoppe, Robert B Marcus, et al.
International Journal of Particle Therapy|November 28, 2019
Race Does Not Affect Tumor Control, Adverse Effects, or Quality of Life after Proton TherapyCurtis Bryant, Bradford S Hoppe, Randal H Henderson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Patient-Reported Sexual Survivorship Following High-Dose Image-Guided Proton Therapy for Prostate CancerAdam L Holtzman, Curtis M Bryant, Nancy P Mendenhall, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2016
Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused UltrasoundAdam L Holtzman, Bradford S Hoppe, Haley P Letter, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppressionWhoon Jong Kil, Romaine C Nichols, Bradford S Hoppe, et al.
American Journal of Clinical Oncology|May 5, 2018
Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker PlacementWilliam M Mendenhall, Gail Sarto, Curtis M Bryant, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate CancerCurtis Bryant, Tamara L Smith, Randal H Henderson, et al.
International Journal of Particle Therapy|August 7, 2018
Patient-Reported Quality of Life in Men with Transurethral Resection of the Prostate Undergoing Proton Therapy for Management of Prostate CancerDerek T Lee, Nancy P Mendenhall, Tamara L Smith, et al.
International Journal of Particle Therapy|November 28, 2019
Bacterial Urinary Tract Infection after Transrectal Placement of Fiducial Markers prior to Proton Radiotherapy for Prostate CancerWilliam M Mendenhall, Gabriella Glassman, Christopher G Morris, et al.
Pageof 6

Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Psycho-Oncology|September 30, 2010
A pilot investigation of a multidisciplinary quality of life intervention for men with biochemical recurrence of prostate cancerSteven C Ames, Winston W Tan, Gretchen E Ames, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Urinary functional outcomes and toxicity five years after proton therapy for low- and intermediate-risk prostate cancer: results of two prospective trialsRandal H Henderson, Bradford S Hoppe, Robert B Marcus, et al.
International Journal of Particle Therapy|November 28, 2019
Race Does Not Affect Tumor Control, Adverse Effects, or Quality of Life after Proton TherapyCurtis Bryant, Bradford S Hoppe, Randal H Henderson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2019
Patient-Reported Sexual Survivorship Following High-Dose Image-Guided Proton Therapy for Prostate CancerAdam L Holtzman, Curtis M Bryant, Nancy P Mendenhall, et al.
International Journal of Radiation Oncology, Biology, Physics|February 18, 2016
Proton Therapy as Salvage Treatment for Local Relapse of Prostate Cancer Following Cryosurgery or High-Intensity Focused UltrasoundAdam L Holtzman, Bradford S Hoppe, Haley P Letter, et al.
Acta Oncologica (Stockholm, Sweden)|March 13, 2013
Hypofractionated passively scattered proton radiotherapy for low- and intermediate-risk prostate cancer is not associated with post-treatment testosterone suppressionWhoon Jong Kil, Romaine C Nichols, Bradford S Hoppe, et al.
American Journal of Clinical Oncology|May 5, 2018
Rectal Culture and Sensitivity Analysis for Reducing Sepsis Risk After Fiducial Marker PlacementWilliam M Mendenhall, Gail Sarto, Curtis M Bryant, et al.
International Journal of Radiation Oncology, Biology, Physics|April 17, 2016
Five-Year Biochemical Results, Toxicity, and Patient-Reported Quality of Life After Delivery of Dose-Escalated Image Guided Proton Therapy for Prostate CancerCurtis Bryant, Tamara L Smith, Randal H Henderson, et al.
International Journal of Particle Therapy|August 7, 2018
Patient-Reported Quality of Life in Men with Transurethral Resection of the Prostate Undergoing Proton Therapy for Management of Prostate CancerDerek T Lee, Nancy P Mendenhall, Tamara L Smith, et al.
International Journal of Particle Therapy|November 28, 2019
Bacterial Urinary Tract Infection after Transrectal Placement of Fiducial Markers prior to Proton Radiotherapy for Prostate CancerWilliam M Mendenhall, Gabriella Glassman, Christopher G Morris, et al.
Pageof 6